AAAAAA

   
Results: 1-3 |
Results: 3
IN-VIVO GENE-TRANSFER THERAPY FOR RECURRENT MALIGNANT CHILDHOOD BRAIN-TUMORS - RESULTS OF A MULTICENTERED PHASE-I STUDY USING GLI-328 HERPES-SIMPLEX VIRUS THYMIDINE GENE-THERAPY
Authors: PACKER RJ RAFFEL C VILLABLANCA J TONN JC BURDACH SE LAFOND D MCCOMB G KAPCALA LP
Citation: Rj. Packer et al., IN-VIVO GENE-TRANSFER THERAPY FOR RECURRENT MALIGNANT CHILDHOOD BRAIN-TUMORS - RESULTS OF A MULTICENTERED PHASE-I STUDY USING GLI-328 HERPES-SIMPLEX VIRUS THYMIDINE GENE-THERAPY, Annals of neurology, 44(3), 1998, pp. 9-9
WHAT IS THE EVIDENCE SUPPORTING CHEMOTHERAPY FOR INTRAOCULAR RETINOBLASTOMA - REPLY
Authors: MURPHREE AL VILLABLANCA J
Citation: Al. Murphree et J. Villablanca, WHAT IS THE EVIDENCE SUPPORTING CHEMOTHERAPY FOR INTRAOCULAR RETINOBLASTOMA - REPLY, Archives of ophthalmology, 115(12), 1997, pp. 1605-1606
ROLE OF MYELOABLATIVE THERAPY IN IMPROVED OUTCOME FOR HIGH-RISK NEUROBLASTOMA - REVIEW OF RECENT CHILDRENS CANCER GROUP RESULTS
Authors: MATTHAY KK OLEARY MC RAMSAY NK VILLABLANCA J REYNOLDS CP ATKINSON JB HAASE GM STRAM DO SEEGER RC
Citation: Kk. Matthay et al., ROLE OF MYELOABLATIVE THERAPY IN IMPROVED OUTCOME FOR HIGH-RISK NEUROBLASTOMA - REVIEW OF RECENT CHILDRENS CANCER GROUP RESULTS, European journal of cancer, 31A(4), 1995, pp. 572-575
Risultati: 1-3 |